Guidelines on the Prevention and Control of Tuberculosis in Ireland

More documents

Recommendations

Info

<strong>Guidelines</strong> on the Prevention and Control of Tuberculosis in Ireland 2010HSE/HPSCAppendix 13: Respiratory hygiene and cough etiquetteThese 3 steps will help prevent the spread of respiratory infectionsWhen coughing or sneezing use a tissue or cover your nose and mouthDispose of the tissues afterwards in a waste binDecontaminate your hands after discarding tissue using soap and water or alcohol gel-187-
<strong>Guidelines</strong> on the Prevention and Control of Tuberculosis in Ireland 2010HSE/HPSCGlossary of TermsAcid-fast Bacilli: Bacteria which having been stained with a dye, retain their colour in acid alcohol. Usedas a technique for microscopic detection of mycobacteria. The relative concentration of AFB per unit areaon a slide (the smear grade) is associated with infectiousness. A positive culture is required for laboratoryconfirmation of M. tuberculosis complex.Active TB: Infection with mycobacteria of the M. tuberculosis complex, where mycobacteria are growingand causing symptoms and signs of disease. This is distinct from LTBI where mycobacteria are present butare inactive and not causing symptoms of disease. The diagnosis of active TB is made most often on thebasis of positive bacteriology but in approximately 15%-25% of cases on the basis of appropriate clinicaland/or radiological and/or pathological presentation as well as treatment response.Adherence: This refers to the patient’s ability or choice to adhere to a treatment regimenAerosol: Small droplets of moisture that are exhaled or coughed up. In a patient with pulmonarytuberculosis they may contain Mycobacterium tuberculosis bacteria that are suspended in the air andlead to the spread of infection. Generation of infectious aerosols is greatest with laryngeal and cavitarypulmonary disease.Air changes per hour (ACH): The number of air changes per hour in a room; one air change being avolume of air equal to the room volumeAirborne isolation: The conditions into which a patient with suspected or proven active tuberculosis maybe placed for purposes of preventing transmission to other persons. In most institutional settings airborneisolation is provided by a combination of increased ventilation (e.g. in the room occupied by the patient)and the use, by staff or visitors, of personal protective wear (respirators that filter 95% of particles of 1micron or larger and have less than 10% leak).Anergy: A condition wherein a person has diminished ability to mount a delayed T-cell hypersensitivityresponse to antigens because of a condition or situation resulting in altered immune function e.g. HIVinfection. When referring to an inability to react to a skin test, the correct term is “cutaneous anergy”.Bacille Calmette-Guerin (BCG) vaccine: A live attenuated vaccine derived from Mycobacterium bovis usedto prevent tuberculosis diseaseBAL: Bronchoalveolar lavage. This is a diagnostic procedure in which small amounts of physiologicalsolution (sterile saline solution) are injected through a fibreoptic bronchoscope into a specific area ofthe lung, while the rest of the lung is sequestered by an inflated balloon. The fluid is then aspirated andinspected for pathogens, malignant cells, and mineral bodies. BAL is typically performed to diagnose lungdisease.Booster phenomenon: The presence of an initially negative TST response followed by a positive responsewhen the test is repeated at any time from 1 week to 1 year later. The phenomenon often occurs manyyears after infection, most notably in the elderly. The initial negative response is based on the subject’sinitial failure to “recall” immunologically, prior infection. To avoid inadvertent labelling of a positiveresponse as due to TST conversion, especially when serial skin testing is planned, initial two-step skintesting may be recommended.Cavitary disease: This is a radiological-pathological label referring to evidence of lung destruction,i.e. evidence on chest X-ray or pathology of cavities or cystic areas that communicate with a bronchus.Cavities generally harbour large numbers of bacteria and, as a result, patients with cavitary disease tend tobe highly infectious.Chemopropylaxis: Treatment of LTBI. The administration of anti-tuberculosis drug (s) to prevent theacquisition of LTBI or progression of LTBI to active TB disease.-188-
Page 2 and 3:
Guidelines on the
Page 4 and 5:
Guidelines on the
Page 6 and 7:
Guidelines on the
Page 8 and 9:
Guidelines on the
Page 10 and 11:
Guidelines on the
Page 12 and 13:
Guidelines on the
Page 14 and 15:
Guidelines on the
Page 16 and 17:
Guidelines on the
Page 18 and 19:
Guidelines on the
Page 20 and 21:
Guidelines on the
Page 22 and 23:
Guidelines on the
Page 24 and 25:
Guidelines on the
Page 26 and 27:
Guidelines on the
Page 28 and 29:
Guidelines on the
Page 30 and 31:
Guidelines on the
Page 32 and 33:
Guidelines on the
Page 34 and 35:
Guidelines on the
Page 36 and 37:
Guidelines on the
Page 38 and 39:
Guidelines on the
Page 40 and 41:
Guidelines on the
Page 42 and 43:
Guidelines on the
Page 44 and 45:
Guidelines on the
Page 46 and 47:
Guidelines on the
Page 48 and 49:
Guidelines on the
Page 50 and 51:
Guidelines on the
Page 52 and 53:
Guidelines on the
Page 54 and 55:
BGuidelines on the
Page 56 and 57:
Guidelines on the
Page 58 and 59:
Guidelines on the
Page 60 and 61:
Guidelines on the
Page 62 and 63:
Guidelines on the
Page 64 and 65:
Guidelines on the
Page 66 and 67:
Guidelines on the
Page 68 and 69:
Guidelines on the
Page 70 and 71:
1♦Guidelines on
Page 72 and 73:
Guidelines on the
Page 74 and 75:
Guidelines on the
Page 76 and 77:
Guidelines on the
Page 78 and 79:
Guidelines on the
Page 80 and 81:
Guidelines on the
Page 82 and 83:
Guidelines on the
Page 84 and 85:
Guidelines on the
Page 86 and 87:
Guidelines on the
Page 88 and 89:
Guidelines on the
Page 90 and 91:
Guidelines on the
Page 92 and 93:
Guidelines on the
Page 94 and 95:
Guidelines on the
Page 96 and 97:
Guidelines on the
Page 98 and 99:
Figure 6.1Patient placement for Pul
Page 100 and 101:
Guidelines on the
Page 102 and 103:
Guidelines on the
Page 104 and 105:
Guidelines on the
Page 106 and 107:
Guidelines on the
Page 108 and 109:
Guidelines on the
Page 110 and 111:
Guidelines on the
Page 112 and 113:
Guidelines on the
Page 114 and 115:
Guidelines on the
Page 116 and 117:
Guidelines on the
Page 118 and 119:
Guidelines on the
Page 120 and 121:
Guidelines on the
Page 122 and 123:
Guidelines on the
Page 124 and 125:
Guidelines on the
Page 126 and 127:
Guidelines on the
Page 128 and 129:
Guidelines on the
Page 130 and 131:
Guidelines on the
Page 132 and 133:
Guidelines on the
Page 134 and 135:
Guidelines on the
Page 136 and 137:
Guidelines on the
Page 138 and 139:
Guidelines on the
Page 140 and 141:
Guidelines on the
Page 142 and 143:
Guidelines on the
Page 144 and 145:
Guidelines on the
Page 146 and 147:
Guidelines on the
Page 148 and 149:
Guidelines on the
Page 150 and 151:
Guidelines on the
Page 152 and 153:
Guidelines on the
Page 154 and 155:
Guidelines on the
Page 156 and 157: Guidelines on the
Page 218: 25-27 Middle Gardiner Street Dublin
show all

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Create successful ePaper yourself

Delete template?

Save as template?